1 Gillison M L,Trotti A M,Harris J,et al.Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer(NRG Oncology RTOG 1016):a randomised,multicentre,non-inferiority trial[J].Lancet(London,England),2019,393(10166):40-50. 2 Zhang J,Jin S,Li X,et al.Human Papillomavirus Type 16 Disables the Increased Natural Killer Cells in Early Lesions of the Cervix[J].J Immunol Res,2019,2019:9182979. 3 Li C,Zhao L,Wang Q,et al.Neutrophils infiltration and its correlation with human papillomavirus status in the oral squamous cell carcinoma[J].Cancer Manag Res 2019,11:5171-5185. 4 Guo Y,Zhang X,Xu Q,et al.Human Papillomavirus 16 oncoprotein E7 retards mitotic progression by blocking Mps1-MAP4 signaling cascade[J].Oncogene,2019,38(31):5959-5970. 5 Zhao J,Lee E E,Kim J,et al.Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus[J].Nat Commun,2019,10(1): 2300. 6 Chakravorty A.Long-distance communication:Looping of human papillomavirus genomes regulates expression of viral oncogenes[J].PLoS Biology,2018,16(11):e3000062. 7 王一羽,原荣,李军,等.商洛、安康、汉中三市女性宫颈人乳头瘤病毒感染基因型别的对比研究[J].中国妇幼保健,2019,34(9):1958-1963. 8 赵丽辉,孙世珺,孟凤娇.中山市4508例女性宫颈细胞HPV基因分型分析[J].现代预防医学,2018,45(22):4086-4088. 9 陈波,黄海樱,周强,等.广州地区女性人乳头状瘤病毒感染的检测及其亚型流行病学调查[J].中国老年学杂志,2018,38(19):4694-4696. 10 王兰芳,胡双婕,葛晓伟,等.HPV不同基因型感染在宫颈病变过程中的研究[J].中华疾病控制杂志,2019,23(5):536-539,544. 11 温先勇,邓正华,彭英,等.西南医科大学附属医院617例人乳头瘤病毒感染者的基因型分布[J].现代预防医学,2018,45(7):1292-1295,1300. 12 吴丹丹,彭丽朵,乔金平,等.合肥地区2558例体检女性HPV感染及亚型分布情况[J].安徽医科大学学报,2018,53(12):1903-1906. 13 李翀,郑旭.天津地区4232例妇女宫颈HPV感染基因谱分析[J].中国妇幼保健,2015,30(10):1571-1573. 14 袁艳,王焰,马莉,等.贵州地区8102例就诊妇女21种HPV亚型检测结果分析[J].检验医学与临床,2014,11(09):1159-1161,1164. 15 朱科静,孙磊,李琴芬,等.2018年长春市及其周边地区15-70岁女性人乳头瘤病毒感染研究[J].中国疫苗和免疫,2019,25(3):292-295. 16 秦晓林,闫恺,段桂开,等.深圳地区36155例女性HPV感染现状与分型研究[J].检验医学与临床,2019,16(8):1037-1039. 17 钟伟娟,吕聪聪,陈建美,等.HPV16感染和雌孕激素水平与宫颈癌的相关性分析[J].中国妇幼保健,2019,34(10):2191-2194. 18 Mehanna H,Bryant T S,Babrah J,et al.Human papillomavirus (HPV)vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK; a cross-sectional study[J].Clin Infect Dis,2019,69(8):1296-1302. 19 Bonneau C,Perrin M,Koskas M,et al.[Epidemiology and risk factors for cancer of the uterus][J].La Revue du praticien,2014,64(6):774-779. 20 Faridi R,Zahra A,Khan K.Oncogenic potential of Human Papillomavirus(HPV)and its relation with cervical cancer[J].Viroly J,2011,8:269. |